Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q4652961> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- Q4652961 subject Q14566194.
- Q4652961 subject Q8431759.
- Q4652961 abstract "ANG1005 is a experimental chemotherapy drug that is under development by a biotechnology company located in Montreal, Canada known as Angiochem Inc. This drug is inserted intravenously and is currently in early clinical stages of development and dose escalation. However, ANG1005 consists of a 19 amino acid long peptide vector known as Angiopep that is conjugated to a taxane derivative involved in mitotic inhibition known as paclitaxel. Various Angiopep vectors have been composed but solely differ by their anti-cancer moieties. This has then been shown to be a prospective cancer therapy drug that can not only be conjugated to paclitaxel but also peptides, monoclonal antibodies, siRNA and many other biological aspects. ANG1005 will then possess the potential to treat a variety of CNS diseases including glioma. Research has shown reduction in tumour growth in mice and rats with glioblastoma tumors.".
- Q4652961 wikiPageExternalLink hp-aad102108.php.
- Q4652961 wikiPageExternalLink 167848.php.
- Q4652961 wikiPageWikiLink Q103135.
- Q4652961 wikiPageWikiLink Q103142.
- Q4652961 wikiPageWikiLink Q1068809.
- Q4652961 wikiPageWikiLink Q1216998.
- Q4652961 wikiPageWikiLink Q134856.
- Q4652961 wikiPageWikiLink Q1365309.
- Q4652961 wikiPageWikiLink Q14566194.
- Q4652961 wikiPageWikiLink Q14599311.
- Q4652961 wikiPageWikiLink Q18029287.
- Q4652961 wikiPageWikiLink Q189159.
- Q4652961 wikiPageWikiLink Q189933.
- Q4652961 wikiPageWikiLink Q21163344.
- Q4652961 wikiPageWikiLink Q221694.
- Q4652961 wikiPageWikiLink Q282142.
- Q4652961 wikiPageWikiLink Q2902757.
- Q4652961 wikiPageWikiLink Q418750.
- Q4652961 wikiPageWikiLink Q423762.
- Q4652961 wikiPageWikiLink Q47273.
- Q4652961 wikiPageWikiLink Q6556752.
- Q4652961 wikiPageWikiLink Q8431759.
- Q4652961 type ChemicalSubstance.
- Q4652961 type Drug.
- Q4652961 type ChemicalObject.
- Q4652961 type Thing.
- Q4652961 type Q8386.
- Q4652961 comment "ANG1005 is a experimental chemotherapy drug that is under development by a biotechnology company located in Montreal, Canada known as Angiochem Inc. This drug is inserted intravenously and is currently in early clinical stages of development and dose escalation. However, ANG1005 consists of a 19 amino acid long peptide vector known as Angiopep that is conjugated to a taxane derivative involved in mitotic inhibition known as paclitaxel.".
- Q4652961 label "ANG1005".